Brief: Aura Biosciences Reports First Quarter 2023 Financial Results
11/05/2023 22:37
May 11 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* AURA BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.46
Source text for Eikon: ID:nBw1f3TDDa
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs